AnswersNow
Personalized, evidence-based autism therapy—accessible everywhere.
Personalized, evidence-based autism therapy—accessible everywhere.
AnswersNow is a company that offers personalized, evidence-based autism therapy which is accessible everywhere. The company, founded in 2017, aims to eliminate barriers to ABA therapy by connecting children to Master’s and PhD-level therapists through an easy-to-use virtual platform. Their slogan emphasizes their commitment to personalized and accessible therapy for autism.
The company, based in the United States, recently secured a $75.00K grant investment on June 27, 2023. The investment was made by VIPC’s Virginia Venture Partners, signifying the industry's confidence in the potential of AnswersNow's virtual platform for autism therapy.
AnswersNow's focus on providing evidence-based therapy through advanced technology showcases its dedication to transforming the accessibility and effectiveness of autism therapy. The recent investment from VIPC’s Virginia Venture Partners underscores the growing interest and support for companies addressing the needs of individuals with autism.
| Funding Stage | Amount | No. Investors | Investors | Date |
|---|---|---|---|---|
| Grant | $75.00K | 1 |
|
27 Jun 2023 |
| Series A | $11.00M | 5 |
|
02 Feb 2023 |
| Convertible Note | Unknown | 1 |
|
01 Mar 2022 |
| Seed Round | Unknown | 1 |
|
10 Oct 2021 |
| Seed Round | Unknown | 2 |
|
01 Jan 2021 |
No recent news or press coverage available for AnswersNow.
We care about your data, and we'd love to use cookies make your experience better.
